On September 1, AmCham China’s Legal Affairs Committee hosted a sold-out event that offered a comprehensive overview of the challenges and opportunities presented by the current anti-corruption landscape in China’s key industries.
The event took place against the backdrop of a nationwide crackdown on corruption in the pharmaceutical sector. Most recently, on July 28, China’s anti-graft agencies announced a comprehensive crackdown in the medical and pharmaceutical industries. The pharmaceutical industry has been a focal point of this ongoing anti-corruption campaign, targeting all aspects and chains of the sector, from production and supply to sales, usage, and reimbursement. However, this anti-corruption wave has not been limited to pharmaceuticals alone. Many other industries have found themselves dealing with similar issues, necessitating a shared approach to handling external investigations, internal inquiries, and common allegations.
During the event, lawyers from Hogan Lovells and Fangda Law Firm delved into several pertinent topics, including:
- Recent enforcement priorities and trends, accompanied by case studies showcasing the latest developments in anti-corruption enforcement within various industries.
- Strategies for anti-corruption compliance and effective defense against allegations.
- Key practical considerations for companies embarking on investigations related to China, such as the handling of personal data, the impact of blocking statutes, and recent compliance trends.
The event also addressed the challenge of collecting WeChat data, which often resides on employees’ personal devices. This discussion was particularly relevant considering China’s increasingly stringent personal information protection regulations. The speakers additionally discussed investigation methods within the life sciences sector.
While this event was hosted by our Legal Affairs Committee, we aimed to provide practical insights that would benefit a wide range of attendees’ job functions, from executive level to HR and management. We hope that participants gained a deeper understanding of how to navigate the complex terrain of anti-corruption enforcement and compliance.”